Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Apr 12;30(5):495–500. doi: 10.1097/CAD.0000000000000758

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/

PMC Copyright notice

Fig. 1 — The combination of T0901317 and gefitinib inhibits the migration and invasion of A549 cells. (a) The migration capability of A549 cells after treatment with the combination of T0901317 and gefitinib was determined by wound-healing assays. (b) Transwell assays showed that the combination of T0901317 and gefitinib decreased A549 cell invasion, **P<0.01 compared with the control. (c) The migration capability of HCC827-8-1 cells after treatment with the combination of T0901317 and gefitinib was determined by wound-healing assays. *P<0.05.